Last reviewed · How we verify

NCT04626154

Thoracoabdominal Asynchrony and Respiratory Distress

Status unknown NA Last updated 10 August 2022
What this trial tests

NA trial testing Objectively monitoring thoracoabdominal asynchrony in Respiratory Insufficiency in 20 participants. Status unknown.

Timeline
16 October 2020
Primary endpoint
31 December 2023
1 June 2024

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposedevice feasibility
Enrollment20
Start date16 October 2020
Primary completion31 December 2023
Estimated completion1 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Adults 28 Days to 17, any sex, with Respiratory Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions. AIMS To determine if the TAA-monitoring device can be used to detect differences in respiratory synchrony in a manner that is clinically applicable. The investigators hope that the device will detect 1) major asynchrony events in a timely manner so as to prompt clinician intervention during future use; and 2) asynchrony events that may be less visible to the naked eye that may be precursors to more severe events.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiratory Insufficiency

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04626154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing